Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 613249, 14 pages
http://dx.doi.org/10.1155/2015/613249
Research Article

Carbon Monoxide Inhibits Tenascin-C Mediated Inflammation via IL-10 Expression in a Septic Mouse Model

1School of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea
2Department of Pharmacology, Dalian University Medical college, Dalian, Liaoning 133000, China
3Joan and Sanford I. Weill Department of Medicine, New York-Presbyterian Hospital, and Division of Pulmonary and Critical Care Medicine, Weill Cornell Medical Center, New York, NY 10065, USA

Received 3 July 2015; Revised 31 August 2015; Accepted 1 September 2015

Academic Editor: Marije I. Koenders

Copyright © 2015 Md. Jamal Uddin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. S. Midwood, T. Hussenet, B. Langlois, and G. Orend, “Advances in tenascin-C biology,” Cellular and Molecular Life Sciences, vol. 68, no. 19, pp. 3175–3199, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Chiquet-Ehrismann and M. Chiquet, “Tenascins: regulation and putative functions during pathological stress,” Journal of Pathology, vol. 200, no. 4, pp. 488–499, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Kaarteenaho-Wiik, E. Lakari, Y. Soini, R. Pollanen, V. L. Kinnula, and P. Paakko, “Tenascin expression and distribution in pleural inflammatory and fibrotic diseases,” Journal of Histochemistry and Cytochemistry, vol. 48, no. 9, pp. 1257–1268, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Päällysaho, K. Tervo, T. Kivelä, I. Virtanen, A. Tarkkanen, and T. Tervo, “Cellular fibronectin and tenascin in an orbital nylon prosthesis removed because of infection caused by Staphylococcus aureus,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 231, no. 2, pp. 61–65, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Schenk, J. Muser, G. Vollmer, and R. Chiquet-Ehrismann, “Tenascin-C in serum: a questionable tumor marker,” International Journal of Cancer, vol. 61, no. 4, pp. 443–449, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Midwood, S. Sacre, A. M. Piccinini et al., “Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease,” Nature Medicine, vol. 15, no. 7, pp. 774–780, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. F. G. Goh, A. M. Piccinini, T. Krausgruber, I. A. Udalova, and K. S. Midwood, “Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation,” Journal of Immunology, vol. 184, no. 5, pp. 2655–2662, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Piccinini and K. S. Midwood, “Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155,” Cell Reports, vol. 2, no. 4, pp. 914–926, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Ekblom, R. Fassler, B. Tomasini-Johansson, K. Nilsson, and P. Ekblom, “Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts,” Journal of Cell Biology, vol. 123, no. 4, pp. 1037–1045, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. P. J. Murray, “Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response,” Current Opinion in Pharmacology, vol. 6, no. 4, pp. 379–386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. O'Garra, F. J. Barrat, A. G. Castro, A. Vicari, and C. Hawrylowicz, “Strategies for use of IL-10 or its antagonists in human disease,” Immunological Reviews, vol. 223, no. 1, pp. 114–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Asadullah, W. Sterry, and H. D. Volk, “Interleukin-10 therapy—review of a new approach,” Pharmacological Reviews, vol. 55, no. 2, pp. 241–269, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. P. J. Murray, “STAT3-mediated anti-inflammatory signalling,” Biochemical Society Transactions, vol. 34, no. 6, pp. 1028–1031, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. S. W. Ryter and L. E. Otterbein, “Carbon monoxide in biology and medicine,” BioEssays, vol. 26, no. 3, pp. 270–280, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. L. E. Otterbein, J. K. Kolls, L. L. Mantell, J. L. Cook, J. Alam, and A. M. K. Choi, “Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury,” Journal of Clinical Investigation, vol. 103, no. 7, pp. 1047–1054, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. P. Soares, Y. Lin, J. Anrather et al., “Expression of heme oxygenase-1 can determine cardiac xenograft survival,” Nature Medicine, vol. 4, no. 9, pp. 1073–1077, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Sawle, R. Foresti, B. E. Mann, T. R. Johnson, C. J. Green, and R. Motterlini, “Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages,” British Journal of Pharmacology, vol. 145, no. 6, pp. 800–810, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Morse, S. E. Pischke, Z. Zhou et al., “Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1,” The Journal of Biological Chemistry, vol. 278, no. 39, pp. 36993–36998, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. T.-S. Lee and L.-Y. Chau, “Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice,” Nature Medicine, vol. 8, no. 3, pp. 240–246, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Yachie, Y. Niida, T. Wada et al., “Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency,” Journal of Clinical Investigation, vol. 103, no. 1, pp. 129–135, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Tsoyi, H. J. Jang, J. W. Kim et al., “Stimulation of Alpha7 nicotinic acetylcholine receptor by nicotine attenuates inflammatory response in macrophages and improves survival in experimental model of sepsis through heme oxygenase-1 induction,” Antioxidants and Redox Signaling, vol. 14, no. 11, pp. 2057–2070, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. F. O. Martinez, A. Sica, A. Mantovani, and M. Locati, “Macrophage activation and polarization,” Frontiers in Bioscience, vol. 13, no. 2, pp. 453–461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. K. S. Midwood and G. Orend, “The role of tenascin-C in tissue injury and tumorigenesis,” Journal of Cell Communication and Signaling, vol. 3, no. 3-4, pp. 287–310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Patel, W. Sun, S. S. Glasson, E. A. Morris, C. R. Flannery, and P. S. Chockalingam, “Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage,” BMC Musculoskeletal Disorders, vol. 12, article 164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. W. Ryter and A. M. Choi, “Therapeutic applications of carbon monoxide in lung disease,” Current Opinion in Pharmacology, vol. 6, no. 3, pp. 257–262, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Motterlini, “Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities,” Biochemical Society Transactions, vol. 35, no. 5, pp. 1142–1146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Motterlini, J. E. Clark, R. Foresti, P. Sarathchandra, B. E. Mann, and C. J. Green, “Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities,” Circulation research, vol. 90, no. 2, pp. E17–E24, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. R.-H. Shih and C.-M. Yang, “Induction of heme oxygenase-1 attenuates lipopolysaccharide-induced cyclooxygenase-2 expression in mouse brain endothelial cells,” Journal of Neuroinflammation, vol. 7, article 86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. E. Otterbein, F. H. Bach, J. Alam et al., “Carbon monoxide has anti-inflammatory effects involving the mitogen- activated protein kinase pathway,” Nature Medicine, vol. 6, no. 4, pp. 422–428, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Inoue, M. Suzuki, Y. Nagashima et al., “Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice,” Human Gene Therapy, vol. 12, no. 8, pp. 967–979, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Oberholzer, C. Oberholzer, and L. L. Moldawer, “Sepsis syndromes: understanding the role of innate and acquired immunity,” Shock, vol. 16, no. 2, pp. 83–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Arnalich, E. Garcia-Palomero, J. López et al., “Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis,” Infection and Immunity, vol. 68, no. 4, pp. 1942–1945, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. T. van der Poll and S. J. H. van Deventer, “Cytokines and anticytokines in the pathogenesis of sepsis,” Infectious Disease Clinics of North America, vol. 13, no. 2, pp. 413–426, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. I. A. Udalova, M. Ruhmann, S. J. P. Thomson, and K. S. Midwood, “Expression and immune function of tenascin-C,” Critical Reviews in Immunology, vol. 31, no. 2, pp. 115–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Kanayama, D. Kurotaki, J. Morimoto et al., “α9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis,” Journal of Immunology, vol. 182, no. 12, pp. 8015–8025, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Kanayama, J. Morimoto, Y. Matsui et al., “α9β1 integrin-mediated signaling serves as an intrinsic regulator of pathogenic Th17 cell generation,” Journal of Immunology, vol. 187, no. 11, pp. 5851–5864, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Bala, M. Marcos, K. Kodys et al., “Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor α (TNFα) production via increased mRNA half-life in alcoholic liver disease,” The Journal of Biological Chemistry, vol. 286, no. 2, pp. 1436–1444, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Tili, J.-J. Michaille, A. Cimino et al., “Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock,” Journal of Immunology, vol. 179, no. 8, pp. 5082–5089, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Wang, Y. Wang, H. P. Kim, K. Nakahira, S. W. Ryter, and A. M. K. Choi, “Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation,” Journal of Biological Chemistry, vol. 282, no. 3, pp. 1718–1726, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Petrache, L. E. Otterbein, J. Alam, G. W. Wiegand, and A. M. K. Choi, “Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 278, no. 2, pp. L312–L319, 2000. View at Google Scholar · View at Scopus
  41. L. Günther, P. O. Berberat, M. Haga et al., “Carbon monoxide protects pancreatic β-cells from apoptosis and improves islet function/survival after transplantation,” Diabetes, vol. 51, no. 4, pp. 994–999, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Togane, T. Morita, M. Suematsu, Y. Ishimura, J.-I. Yamazaki, and S. Katayama, “Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 278, no. 2, pp. H623–H632, 2000. View at Google Scholar · View at Scopus
  43. A. Nakao, A. M. K. Choi, and N. Murase, “Protective effect of carbon monoxide in transplantation,” Journal of Cellular and Molecular Medicine, vol. 10, no. 3, pp. 650–671, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. S. W. Ryter, J. Alam, and A. M. K. Choi, “Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications,” Physiological Reviews, vol. 86, no. 2, pp. 583–650, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Motterlini, B. E. Mann, T. R. Johnson, J. E. Clark, R. Foresti, and C. J. Green, “Bioactivity and pharmacological actions of carbon monoxide-releasing molecules,” Current Pharmaceutical Design, vol. 9, no. 30, pp. 2525–2539, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. L.-C. Lin, F.-M. Ho, S.-J. Yen et al., “Carbon monoxide induces cyclooxygenase-2 expression through MAPKs and PKG in phagocytes,” International Immunopharmacology, vol. 10, no. 12, pp. 1520–1525, 2010. View at Publisher · View at Google Scholar · View at Scopus